Trial intelligence / Profile preview

Paliperidone ER in Adolescents and Young Adults With Autism

NCT00549562Phase 3Completed

Sponsor
Indiana University School of Medicine
Start
Nov 2007
Primary completion
Sep 2010
Modality
Small Molecules
Countries
1
01

Overview

A Phase 3 trial of paliperidone in Autism Spectrum Disorder (ASD), sponsored by Indiana University School of Medicine. Started Nov 2007; status: completed.

02

Drugs

paliperidone
03

Conditions

Autism Spectrum Disorder (ASD)

Beyond the preview

Go deeper on NCT00549562.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT00549562.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call